soul trial oral semaglutide cardiovascular outcomes nejm 2025 results A emulation in Nature Medicine shows that treatment with and tirzepatide showed similar levels of benefit on in people at elevated cardiovascular risk with obesity and diabetes. Link Oral Semaglutide and Cardiovascular Outcomes

It is seen across a range of peptides and pharmaceutical compounds that carry ionic or charged components, particularly when those compounds are injected into sensitive or low-fat tissue without adequate buffering

Staying at a dose for 6-8 weeks instead of the minimum 4 gives your body significantly more time to adapt before the next increase

Common side effects counting: Nausea Diarrhea Vomiting Constipation Abdominal pain These gastrointestinal severe side effects usually move from mild to moderate in strength and tend to decrease over time as the body adjusts to the medication

In Canada, prescription drugs include both active and inactive ingredients, and while a name-brand drugs active ingredients may be the same as a generics, inactive ingredients (also called excipients) may differ